MMP9 and chronic obstructive pulmonary disease: In our study, the level of MMP-9 in the COPD group was significantly upregulated compared to that in the Naïve group, and the level was significantly decreased in the AGE group (Figure 4n), which contributed to the attenuation of alveolar destruction (Figure 5a).